【摘要】 目的评价¹³¹I辅助保肝措施治疗甲亢合并肝损害的临床疗效。方法回顾性分析120例经¹³¹I及保肝治疗的甲亢合并肝损害患者的随访资料。结果甲亢经¹³¹I治疗后的痊愈率在第6、12个月分别为83.33%、89.16%;甲减率分别为10.83%、10.83%。与治疗前相比,血清转氨酶指标均明显下降,差异有统计学意义（P<0.05）。结论 ¹³¹I辅助保肝措施治疗甲亢合并肝损害疗效显著,值得进一步推广。更多还原

【Abstract】 Objective To analyze the clinical treatment and the curative efficiency of hyperthyroidism patients with liver injury.Methods Retrospective analysis was used in studying 120 cases of hyperthyroidism patients with liver injury treated by ¹³¹I.Results The total effectiveness of hyperthyroidism were 83.33%and 89.16%respectively at ¹³¹I therapy at 6th month and 12th month.The rates of hypothyroidism were 10.83%and 10.83%respectively.The serum tranaminase levels were remarkably lower than pretreatment.The difference was significant（P<0.05）.Conclusion ¹³¹I is effective in treating hyperthyroidism patients with liver injury,and is worthy of clinical promotion.更多还原